Author

M. Kassem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Rauch· 1 shared B. Hartmann· 1 shared B. Ramaswamy· 1 shared C. C. Coss· 1 shared C. E. Bennett· 1 shared C. M. Gorvin· 1 shared C. Martin· 1 shared D. Stover· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Rauch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GIP receptor reduces osteoclast activity and improves osteoblast survival by activating multiple signaling pathways

M. S. Hansen, K. Soe, L. L. Christensen, P. Fernandez-Guerra, N. W. Hansen, R. A. Wyatt, C. Martin, R. S. Hardy, T. L. Anderson, J. B. Olesen, S. Overgaard, B. Hartmann, M. M. Rosenkilde, M. Kassem, A. Rauch, , M. Frost

This study shows GIP reduces osteoclast activity and improves osteoblast survival through multiple signaling pathways, suggesting GIPR agonism could treat osteoporosis.

bioRxiv · Jul 2, 2022Cell Biology

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

J. Datta, N. Willingham, J. Manouchehri, P. Schnell, M. Sheth, J. J. David, M. Kassem, T. A. Wilson, H. S. Radomska, C. C. Coss, C. E. Bennett, R. K. Ganju, S. D. Sardesai, M. Lustberg, B. Ramaswamy, , M. A. Cherian

This study shows that selective ERβ agonists reduce viability of ER+ breast cancer cells and suggest their potential as a therapeutic strategy when combined with ER blockade.

bioRxiv · Jan 14, 2022Cancer Biology